Health Blueprint

Back to Longevity News

News summary

Vale Biolabs receives €164K from Venture Kick to advance brain disease research

Source: Tech.eu • Published: 09 Nov 2026, 09:30

Summarized by Masters of Longevity from Tech.eu.

Vale Biolabs won €164,000 to advance automated brain organoids and predictive AI.

Vale Biolabs receives €164K from Venture Kick to advance brain disease research
Key Takeaways
  • Vale Biolabs received €164,000 from Venture Kick.
  • The firm is developing standardized human brain organoids with automation.
  • This funding will expand models and generate datasets for AI.
Read the full article at Tech.eu ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickLongevity is leaving the clinicStephen Watson argues that hotels, gyms and residential communities can build longevity memberships around the relationships they already have.